₹202.5*
MRP ₹225
10% off
₹191.25*
MRP ₹225
15% CB
₹33.75 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Prescription drugWhats That
Composition
CLINDAMYCIN-1%W/W
Manufacturer/Marketer
Dermajoint India
Consume Type
TOPICAL
Return Policy
Not Returnable
Expires on or after
Jan-27
for this medicine
Drug-Drug Interactions
No Drug - Drug interactions found in our data. We may lack specific data on this medicine and are actively working to update our database. Consult your doctor for personalized advice
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Wegamycin Gel Substitute
Clindac A Gel 20 gm | Clindamycin | Treats Acne & Pimple
by Others
₹12.00per tabletClear Gel 20 gm | Clindamycin | Treats Acne & Pimple
by Others
₹8.80per tabletErytop Gel 20 gm | Clindamycin | For Treatment Of Acne & Pimple
by Others
₹8.55per tabletClenz-AC Topical Gel 15 gm
by Others
₹35.00per tabletZyclin Nano Gel 15 gm
by Others
₹16.50per tablet
Product Substitutes
Author Details
Drug-Diseases Interactions
CLINDAMYCIN-1%W/WOther bacterial intestinal infections
Severe
CLINDAMYCIN-1%W/WDisorders related to short gestation and low birth weight, not elsewhere classified
Severe
Drug-Diseases Interactions
Login/Sign Up
CLINDAMYCIN-1%W/WOther bacterial intestinal infections
Severe
How does the disease interact with Wegamycin Gel 15 gm:
Almost all antibacterial medications have been associated with reports of Clostridioides difficile-associated diarrhoea (CDAD), formerly known as pseudomembranous colitis. It can vary from mild diarrhoea to deadly colitis.
How to manage the interaction:
Clostridioides difficile-associated diarrhea (CDAD) ranging from mild diarrhoea to colitis has been reported during treatment with antibacterial agents. Therapy should be administered cautiously in patients with history of gastrointestinal disease, particularly colitis and pseudomembranous colitis. Appropriate fluid and electrolyte management, protein supplementation, and antibacterial treatment of C difficile is advised.
Almost all antibacterial medications have been associated with reports of Clostridioides difficile-associated diarrhoea (CDAD), formerly known as pseudomembranous colitis. It can vary from mild diarrhoea to deadly colitis.
How to manage the interaction:
Clostridioides difficile-associated diarrhea (CDAD) ranging from mild diarrhoea to colitis has been reported during treatment with antibacterial agents. Therapy should be administered cautiously in patients with history of gastrointestinal disease, particularly colitis and pseudomembranous colitis. Appropriate fluid and electrolyte management, protein supplementation, and antibacterial treatment of C difficile is advised.
CLINDAMYCIN-1%W/WDisorders related to short gestation and low birth weight, not elsewhere classified
Severe
How does the disease interact with Wegamycin Gel 15 gm:
Benzyl alcohol is frequently used as a preservative in the formulation of multidose vials for parenteral medicines. Manufacturers of pharmaceuticals believe that using them in neonates, especially preterm and underweight newborns, is contraindicated. In low birth weight preterm newborns, the use of benzyl alcohol in bacteriostatic saline intravascular flush and endotracheal tube lavage solutions has been linked to mortality and serious respiratory and metabolic problems.
How to manage the interaction:
Parenteral medications containing benzyl alcohol as a preservative are contraindicated in neonates, particularly premature infants and infants of low birth weight.
Benzyl alcohol is frequently used as a preservative in the formulation of multidose vials for parenteral medicines. Manufacturers of pharmaceuticals believe that using them in neonates, especially preterm and underweight newborns, is contraindicated. In low birth weight preterm newborns, the use of benzyl alcohol in bacteriostatic saline intravascular flush and endotracheal tube lavage solutions has been linked to mortality and serious respiratory and metabolic problems.
How to manage the interaction:
Parenteral medications containing benzyl alcohol as a preservative are contraindicated in neonates, particularly premature infants and infants of low birth weight.
CLINDAMYCIN-1%W/WOther diseases of liver
Moderate
How does the disease interact with Wegamycin Gel 15 gm:
The liver is the primary site of Wegamycin Gel 15 gm metabolism. Patients with significantly impaired hepatic function may have a rise in the blood concentration of Wegamycin Gel 15 gm and a prolongation of the half-life. Additionally, the drug's usage may result in abnormal liver enzyme levels and jaundice. Patients with liver problems should receive Wegamycin Gel 15 gm therapy with caution. When given every 8 hours, dosage modifications might not be required. However, with high-dose therapy, serum concentrations should be observed, and during prolonged therapy, regular liver function tests should be carried out.
How to manage the interaction:
Wegamycin Gel 15 gm is primarily metabolized by the liver. Therapy with Wegamycin Gel 15 gm should be administered cautiously in patients with liver disease. Serum concentrations should be monitored during high-dose therapy, and periodic liver function tests should be performed during prolonged therapy.
The liver is the primary site of Wegamycin Gel 15 gm metabolism. Patients with significantly impaired hepatic function may have a rise in the blood concentration of Wegamycin Gel 15 gm and a prolongation of the half-life. Additionally, the drug's usage may result in abnormal liver enzyme levels and jaundice. Patients with liver problems should receive Wegamycin Gel 15 gm therapy with caution. When given every 8 hours, dosage modifications might not be required. However, with high-dose therapy, serum concentrations should be observed, and during prolonged therapy, regular liver function tests should be carried out.
How to manage the interaction:
Wegamycin Gel 15 gm is primarily metabolized by the liver. Therapy with Wegamycin Gel 15 gm should be administered cautiously in patients with liver disease. Serum concentrations should be monitored during high-dose therapy, and periodic liver function tests should be performed during prolonged therapy.
CLINDAMYCIN-1%W/WOther disorders of kidney and ureter, not elsewhere classified
Moderate
How does the disease interact with Wegamycin Gel 15 gm:
Wegamycin Gel 15 gm is partially removed by the kidney. Wegamycin Gel 15 gm should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Wegamycin Gel 15 gm concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Wegamycin Gel 15 gm should be administered cautiously in patients with severely impaired renal function. Serum Wegamycin Gel 15 gm concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
Wegamycin Gel 15 gm is partially removed by the kidney. Wegamycin Gel 15 gm should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Wegamycin Gel 15 gm concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Wegamycin Gel 15 gm should be administered cautiously in patients with severely impaired renal function. Serum Wegamycin Gel 15 gm concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
CLINDAMYCIN-1%W/WOther disorders of kidney and ureter, not elsewhere classified
Moderate
How does the disease interact with Wegamycin Gel 15 gm:
Wegamycin Gel 15 gm is partially removed by the kidney. Wegamycin Gel 15 gm should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Wegamycin Gel 15 gm concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Wegamycin Gel 15 gm should be administered cautiously in patients with severely impaired renal function. Serum Wegamycin Gel 15 gm concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
Wegamycin Gel 15 gm is partially removed by the kidney. Wegamycin Gel 15 gm should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Wegamycin Gel 15 gm concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.
How to manage the interaction:
Therapy with Wegamycin Gel 15 gm should be administered cautiously in patients with severely impaired renal function. Serum Wegamycin Gel 15 gm concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.
